You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our Ret Proto-Oncogene (RET) ELISA Kits

Full name:
Ret Proto-Oncogene ELISA Kits (RET)
On are 14 Ret Proto-Oncogene (RET) ELISA Kits from 6 different suppliers available. Additionally we are shipping Ret Proto-Oncogene Antibodies (329) and Ret Proto-Oncogene Proteins (31) and many more products for this protein. A total of 394 Ret Proto-Oncogene products are currently listed.
c-Ret, CDHF12, CDHR16, cret, etID315074.13, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET, ret-A, RET-ELE1, ret1, RET9, RET51, wu:fd13h01, X-ret, xret
list all ELISA KIts Gene Name GeneID UniProt
RET 5979 P07949
RET 19713 P35546
RET 24716  

Show all species

Show all synonyms

Ret Proto-Oncogene (RET) ELISA Kits by Reactivity

Select your species

More ELISA Kits for Ret Proto-Oncogene Interaction Partners

Zebrafish Ret Proto-Oncogene (RET) interaction partners

  1. RET expression is investigated within the brain of zebrafish; both RET protein and mRNA are observed.

  2. In animals lacking Ret or Gfra3 (show GFRA3 ELISA Kits) function, myogenic gene expression is reduced in forming opercular muscles, but not in non-opercular muscles derived from the same muscle anlagen.

  3. evaluation of noncoding sequences at the zebrafish ret locus conserved among teleosts, and at the human RET locus, conserved among mammals

  4. genes beyond RET may be implicated in the genesis of sporadic cases of HD

Human Ret Proto-Oncogene (RET) interaction partners

  1. Study reports the coexistence of a germline intronic heterozygote variation at the MEN1 (show MEN1 ELISA Kits) gene (IVS4+1G>T) and a germline mutation of exon 11 of RET proto-oncogene (K666M) in a large Italian family and describes clinical manifestations in the carriers.

  2. the RET p.S891A mutation combined with OSMR (show OSMR ELISA Kits) p.G513D may underlie a novel phenotype manifesting as familial medullary thyroid carcinoma and cutaneous amyloidosis

  3. Presence of a RET fusion kinase may identify a subset of metastatic colorectal cancer patients with a high response rate to RET kinase inhibition.

  4. Lung adenocarcinomas with RET and ROS1 fusions share many radiographic features.

  5. the frequency profile of RET mutations in the Azari population of Iran with Medullary thyroid carcinoma (MTC (show MT1A ELISA Kits)) is 61.7%.

  6. The combined effect of the 2 mutations (Val648Ile + Val804Leu) may have induced the development of pheochromocytoma (PHEO) in this patient within a MEN2a family.

  7. The RET S836S polymorphism is in linkage disequilibrium with 3'UTR (show UTS2R ELISA Kits) variants.

  8. This study conducts miRNA profiling and shows disregulation of RET and its regulating signaling pathways in Hirschsprung's Disease patients.

  9. Studies indicate that RET proto-oncogene fusion gene occurred predominantly in Asian females with younger age, in non-smokers, and in lung adenocarcinomas patients.

  10. after 20 years of the molecular and epidemiological research of RET/PTC in thyroid radiogenic carcinomas the comprehensive evidence of the dose-effect dependence existence indicating a real relationship between the studied parameters and radiation factor

Mouse (Murine) Ret Proto-Oncogene (RET) interaction partners

  1. Ret and Gfra2 (show GFRA2 ELISA Kits) null mice display comparable early central projection deficits, but Gfra2 (show GFRA2 ELISA Kits) null rapidly adapting mechanoreceptors recover later.

  2. Parkin (show PARK2 ELISA Kits) and the RET signaling cascade converge to control mitochondrial integrity and thereby properly maintain substantia nigra pars (show EPRS ELISA Kits) compacta dopaminergic neurons and their innervation in the striatum.

  3. the Ret signaling pathway is important for podocyte survival and recovery from glomerular injury in vivo

  4. RET coupling to ERK (show EPHB2 ELISA Kits) and Akt (show AKT1 ELISA Kits) depends strongly on artemin (show ARTN ELISA Kits) concentration, and it is highest at the low (~100 pM) artemin (show ARTN ELISA Kits) levels required for neurite outgrowth.

  5. we analysed non-thermal, atmospheric pressure, plasma irradiation mediated effects in melanocytic tumors which spontaneously developed in HL-RET-mice

  6. the important IL-10 (show IL10 ELISA Kits) transcription factor Maf (show MAF ELISA Kits) was upregulated in RET-deficient Th2 cells and down-regulated upon RET signalling activation by glial-derived neurotrophic factor (show NTF3 ELISA Kits) family ligands.

  7. the neurotrophic factor (show NTF3 ELISA Kits) receptor RET drives haematopoietic stem cell survival, expansion and function; haematopoietic stem cells express RET and its neurotrophic factor (show NTF3 ELISA Kits) partners are produced in the haematopoietic stem cell environment

  8. TNFR1 (show TNFRSF1A ELISA Kits) exerts a dual role in nociceptor information processing by suppressing TrkA (show NTRK1 ELISA Kits) and enhancing Ret signaling in peptidergic and nonpeptidergic nociceptors, respectively.

  9. only the SH3 domains of CD2AP (show Cd2ap ELISA Kits) are necessary to enhance the E3 ligase activity of Cbl-3 (show CBLC ELISA Kits)/c toward Ret51

  10. These data establish mTOR (show FRAP1 ELISA Kits) as a key mediator of RET-mediated cell growth in thyroid cancer cells and provide a rationale for combinatorial treatments in thyroid cancers with oncogenic RET mutations.

Ret Proto-Oncogene (RET) Antigen Profile

Antigen Summary

This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma. Two transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their biological validity has not been confirmed.

Alternative names and synonyms associated with Ret Proto-Oncogene (RET)

  • ret proto-oncogene receptor tyrosine kinase (ret) Elisa Kit
  • ret proto-oncogene (ret) Elisa Kit
  • ret proto-oncogene (RET) Elisa Kit
  • ret proto-oncogene (Ret) Elisa Kit
  • c-Ret Elisa Kit
  • CDHF12 Elisa Kit
  • CDHR16 Elisa Kit
  • cret Elisa Kit
  • etID315074.13 Elisa Kit
  • HSCR1 Elisa Kit
  • MEN2A Elisa Kit
  • MEN2B Elisa Kit
  • MTC1 Elisa Kit
  • PTC Elisa Kit
  • RET Elisa Kit
  • ret-A Elisa Kit
  • RET-ELE1 Elisa Kit
  • ret1 Elisa Kit
  • RET9 Elisa Kit
  • RET51 Elisa Kit
  • wu:fd13h01 Elisa Kit
  • X-ret Elisa Kit
  • xret Elisa Kit

Protein level used designations for Ret Proto-Oncogene (RET) ELISA Kits

proto-oncogene tyrosine-protein kinase receptor Ret , receptor tyrosine kinase , ret proto-oncogene , tryptase , proto-oncogene tyrosine-protein kinase receptor Ret-like , RET transforming sequence , cadherin family member 12 , cadherin-related family member 16 , hydroxyaryl-protein kinase , proto-oncogene c-Ret , ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) , Ret gene for receptor tyrosin , Ret proto-oncogene (multiple endocrine neoplasia MEN2A MEN2B and medullary thyroid carcinoma 1 Hirschsprung disease) , ret tyrosine kinase

30512 Danio rerio
373625 Xenopus laevis
449594 Pan troglodytes
703466 Macaca mulatta
100033966 Equus caballus
100403596 Callithrix jacchus
100442682 Pongo abelii
100467317 Ailuropoda melanoleuca
100495902 Xenopus (Silurana) tropicalis
100602103 Nomascus leucogenys
5979 Homo sapiens
19713 Mus musculus
24716 Rattus norvegicus
403494 Canis lupus familiaris
396107 Gallus gallus
515924 Bos taurus
100340710 Oryctolagus cuniculus
100733392 Cavia porcellus
Selected quality suppliers for Ret Proto-Oncogene (RET) ELISA Kits
Did you look for something else?